Terenia Custer, PA
Medical · Sterling Heights, MINPI 1124204896
Payments from drug & device makers
Across 188 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$932
- Johnson & Johnson$650
- AbbVie$304
- Pfizer$295
- Sanofi$258
- E.r. Squibb & Sons, L.L.C.$160
- plus $928 from 15 others
What the payments were for
- Food & beverage$3,23692%
- Education$2918%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 62 | $932 |
| Johnson & Johnson | 28 | $650 |
| AbbVie(2 entities) | 17 | $304 |
| Pfizer | 15 | $295 |
| Sanofi | 12 | $258 |
| E.r. Squibb & Sons, L.L.C. | 7 | $160 |
| Lilly USA, LLC | 7 | $140 |
| LEO Pharma Inc. | 6 | $127 |
| EPI Health, LLC | 7 | $113 |
| VYNE Pharmaceuticals Inc. | 3 | $89 |
| Regeneron Healthcare Solutions, Inc. | 5 | $88 |
| Dermavant Sciences, Inc. | 4 | $75 |
| Galderma Laboratories, L.p. | 3 | $62 |
| UCB, Inc. | 2 | $46 |
| Mayne Pharma Commercial LLC | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
| Sun Pharmaceutical Industries Inc. | 2 | $33 |
| Incyte Corporation | 1 | $24 |
| Almirall LLC | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Organon | 1 | $17 |
How this compares
$3,527 in reported general payments places this provider in the 80th percentile of 755 medical providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 11 | $98,447 |
| Taltz AutoinjectorIxekizumab | 12 | $82,896 |
| Fluorouracil | 21 | $1,311 |
| Ketoconazole | 67 | $1,207 |
| Metronidazole | 19 | $801 |
| Clobetasol Propionate | 17 | $421 |
| Triamcinolone Acetonide | 76 | $392 |
| Ciclopirox | 13 | $331 |
| ValacyclovirValacyclovir Hcl | 11 | $218 |
| Mometasone Furoate | 11 | $190 |
| Mupirocin | 11 | $94 |
| Doxycycline Monohydrate | 14 | $88 |
| CiclopiroxCiclopirox Olamine | 13 | $78 |
| Hydrocortisone | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other medical in Sterling Heights
- Brooke TobiaSterling Heights$15K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.